T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Magnolia Oil & Gas
MGY
$6.13B
| $65.9M | 0.01% |
16,464,506
+4,168,350
| +34% | +$35.9M |
|
702
General Mills
GIS
$20.8B
| $65.6M | 0.01% |
1,242,950
+97,418
| +9% | +$5.14M |
|
703
SPX Corp
SPXC
$10.6B
| $65.6M | 0.01% |
2,008,992
+357,644
| +22% | +$16.1M |
|
704
Live Oak Bancshares
LOB
$2.01B
| $64.2M | 0.01% |
5,146,703
-29,090
| -0.6% | -$460K |
|
|
ONC
705
BeOne Medicines Ltd
ONC
$40.3B
| $64.2M | 0.01% |
521,140
-68,285
| -12% | -$10.7M |
|
706
Haemonetics
HAE
$4.11B
| $62.7M | 0.01% |
629,401
+3,491
| +0.6% | +$379K |
|
707
Hershey
HSY
$37.4B
| $62.7M | 0.01% |
473,301
+23,989
| +5% | +$3.54M |
|
708
Portland General Electric
POR
$5.92B
| $62.7M | 0.01% |
1,308,114
+49,318
| +4% | +$2.76M |
|
709
Allstate
ALL
$65.9B
| $62.7M | 0.01% |
683,110
+51,679
| +8% | +$5.62M |
|
710
General Dynamics
GD
$106B
| $62.6M | 0.01% |
472,913
+27,450
| +6% | +$4.56M |
|
711
Watsco Inc
WSO
$12.9B
| $62.5M | 0.01% |
395,513
+10,586
| +3% | +$1.79M |
|
712
Pennant Group
PNTG
$1.35B
| $62.3M | 0.01% |
4,403,005
+57,889
| +1% | +$1.47M |
|
713
Mueller Water Products
MWA
$3.98B
| $62.3M | 0.01% |
7,781,871
-145,251
| -2% | -$1.6M |
|
714
Maximus
MMS
$2.94B
| $62.2M | 0.01% |
1,069,257
-8,233
| -0.8% | -$559K |
|
715
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.44B
| $61M | 0.01% |
2,989,925
+345,678
| +13% | +$10.9M |
|
|
DCPH
716
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $60.8M | 0.01% |
1,475,821
-215,648
| -13% | -$12M |
|
717
Ametek
AME
$58.7B
| $60.7M | 0.01% |
843,267
-50,109
| -6% | -$4.52M |
|
718
WEC Energy
WEC
$35.9B
| $60.7M | 0.01% |
688,693
+52,294
| +8% | +$5.03M |
|
719
Origin Bancorp
OBK
$1.69B
| $60.4M | 0.01% |
2,981,130
+119,093
| +4% | +$3.72M |
|
720
Independent Bank
INDB
$4.05B
| $60.1M | 0.01% |
934,162
-56,344
| -6% | -$4.02M |
|
|
BLUE
721
DELISTED
bluebird bio
BLUE
| $60.1M | 0.01% |
100,937
-27,282
| -21% | -$26.6M |
|
722
Knowles
KN
$3.23B
| $60.1M | 0.01% |
4,489,875
+72,511
| +2% | +$1.26M |
|
|
TPTX
723
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $60M | 0.01% |
1,342,539
-152,887
| -10% | -$8.12M |
|
724
FedEx
FDX
$80.3B
| $59.9M | 0.01% |
493,950
+37,493
| +8% | +$5.28M |
|
725
KT
KT
$9.03B
| $59.9M | 0.01% |
7,698,095
+738,080
| +11% | +$7.32M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.